Research ArticleOriginal Article

Diagnostic value of whole-body MRI with diffusion-weighted sequence for detection of peritoneal metastases in colorectal malignancy

Huan Zhang, Weixing Dai, Caixia Fu, Xu Yan, Alto Stemmer, Tong Tong and Guoxiang Cai
Cancer Biology & Medicine May 2018, 15 (2) 165-170; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0162

References

  1. 1.↵
    2. Koppe MJ,
    3. Boerman OC,
    4. Oyen WJG,
    5. Bleichrodt RP.
    Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies. Ann Surg. 2006; 243: 212–22.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    2. Franko J,
    3. Shi Q,
    4. Goldman CD,
    5. Pockaj BA,
    6. Nelson GD,
    7. Goldberg RM, et al.
    Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841. J Clin Oncol. 2012; 30: 263–7.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    2. Sugarbaker PH
    2. Jacquet P,
    3. Sugarbaker PH.
    Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Peritoneal Carcinomatosis: Principles of Management. In: Sugarbaker PH. Boston, MA: Springer. 1996; 82: 359–74.
    OpenUrl
  4. 4.↵
    2. Koh JL,
    3. Yan TD,
    4. Glenn D,
    5. Morris DL.
    Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis. Ann Surg Oncol. 2009; 16: 327–33.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    2. Glehen O,
    3. Gilly FN.
    Quantitative prognostic indicators of peritoneal surface malignancy: carcinomatosis, sarcomatosis, and peritoneal mesothelioma. Surg Oncol Clin N Am. 2003: 649–71.
  6. 6.↵
    2. Harmon RL,
    3. Sugarbaker PH.
    Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer. Int Semin Surg Oncol. 2005; 2: 3.
    OpenUrlCrossRefPubMed
  7. 7.↵
    2. Baratti D,
    3. Kusamura S,
    4. Deraco M.
    The fifth international workshop on peritoneal surface malignancy (Milan, Italy, December 4-6, 2006): methodology of disease-specific consensus. J Surg Oncol. 2008; 98: 258–62.
    OpenUrlCrossRefPubMed
  8. 8.
    2. Metser U,
    3. Jones C,
    4. Jacks LM,
    5. Bernardini MQ,
    6. Ferguson S.
    Identification and quantification of peritoneal metastases in patients with ovarian cancer with multidetector computed tomography: correlation with surgery and surgical outcome. Int J Gynecol Cancer. 2011; 21: 1391–8.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    2. Esquivel J,
    3. Chua TC,
    4. Stojadinovic A,
    5. Melero JT,
    6. Levine EA,
    7. Gutman M, et al.
    Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: a multi-institutional study. J Surg Oncol. 2010; 102: 565–70.
    OpenUrlCrossRefPubMed
  10. 10.↵
    2. Bozkurt M,
    3. Doganay S,
    4. Kantarci M,
    5. Yalcin Y,
    6. Eren S,
    7. Atamanalp SS, et al.
    Comparison of peritoneal tumor imaging using conventional MR imaging and diffusion-weighted MR imaging with different b values. Eur J Radiol. 2011; 80: 224–8.
    OpenUrlCrossRefPubMed
  11. 11.↵
    2. Fehniger J,
    3. Thomas S,
    4. Lengyel E,
    5. Liao CH,
    6. Tenney M,
    7. Oto A, et al.
    A prospective study evaluating diffusion weighted magnetic resonance imaging (DW-MRI) in the detection of peritoneal carcinomatosis in suspected gynecologic malignancies. Gynecol Oncol. 2016; 142: 169–75.
    OpenUrl
  12. 12.
    2. Barral M,
    3. Eveno C,
    4. Hoeffel C,
    5. Boudiaf M,
    6. Bazeries P,
    7. Foucher R, et al.
    Diffusion-weighted magnetic resonance imaging in colorectal cancer. J Visc Surg. 2016; 153: 361–9.
    OpenUrl
  13. 13.↵
    2. Fujii S,
    3. Matsusue E,
    4. Kanasaki Y,
    5. Kanamori Y,
    6. Nakanishi J,
    7. Sugihara S, et al.
    Detection of peritoneal dissemination in gynecological malignancy: evaluation by diffusion-weighted MR imaging. Eur Radiol. 2008; 18: 18–23.
    OpenUrlCrossRefPubMed
  14. 14.
    2. Klumpp BD,
    3. Aschoff P,
    4. Schwenzer N,
    5. Fenchel M,
    6. Koenigsrainer I,
    7. Falch C, et al.
    Peritoneal carcinomatosis: comparison of dynamic contrast-enhanced magnetic resonance imaging with surgical and histopathologic findings. Abdom Radiol. 2012; 37: 834–42.
    OpenUrl
  15. 15.↵
    2. Michielsen K,
    3. Dresen R,
    4. Vanslembrouck R,
    5. De Keyzer F,
    6. Amant F,
    7. Mussen E, et al.
    Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer. Eur J Cancer. 2017; 83: 88–98.
    OpenUrlPubMed
  16. 16.↵
    2. Levine EA,
    3. Stewart IV JH,
    4. Russell GB,
    5. Geisinger KR,
    6. Loggie BL,
    7. Shen P.
    Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: experience with 501 procedures. J Am Coll Surg. 2007; 204: 943–53.
    OpenUrlCrossRefPubMed
  17. 17.
    2. Blackham AU,
    3. Russell GB,
    4. Stewart IV JH,
    5. Votanopoulos K,
    6. Levine EA,
    7. Shen P.
    Metastatic colorectal cancer: survival comparison of hepatic resection vs. cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2014; 21: 2667–74.
    OpenUrl
  18. 18.
    2. Weber T,
    3. Roitman M,
    4. Link KH.
    Current status of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer. Clin Colorectal Cancer. 2012; 11: 167–76.
    OpenUrlPubMed
  19. 19.↵
    2. Hornung M,
    3. Werner JM,
    4. Schlitt HJ.
    Applications of hyperthermic intraperitoneal chemotherapy for metastatic colorectal cancer. Expert Rev Anticancer Ther. 2017; 17: 841–50.
    OpenUrl
  20. 20.↵
    2. Yan TD,
    3. Sim J,
    4. Morris DL.
    Selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and perioperative intraperitoneal chemotherapy. Ann Surg Oncol. 2007; 14: 1807–17.
    OpenUrlCrossRefPubMed
  21. 21.↵
    2. Goéré D,
    3. Malka D,
    4. Tzanis D,
    5. Gava V,
    6. Gava V,
    7. Eveno C, et al.
    Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy? Ann Surg. 2013; 257: 1065–71.
    OpenUrl
  22. 22.↵
    2. Yonemura Y,
    3. Tsukiyama G,
    4. Miyata R,
    5. Sako S,
    6. Endou Y,
    7. Hirano M, et al.
    Indication of peritonectomy for peritoneal dissemination. Gan to Kagaku Ryoho. 2010; 37: 2306–11.
    OpenUrlPubMed
  23. 23.↵
    2. Turaga K,
    3. Levine E,
    4. Barone R,
    5. Sticca R,
    6. Petrelli N,
    7. Lambert L, et al.
    Consensus guidelines from the American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States. Ann Surg Oncol. 2014; 21: 1501–5.
    OpenUrlCrossRefPubMed
  24. 24.↵
    2. Mo SB,
    3. Cai GX.
    Multidisciplinary treatment for colorectal peritoneal metastases: Review of the literature. Gastroenterol Res Pract. 2016; 2016: 1516259.
    OpenUrl
  25. 25.↵
    2. De Bree E,
    3. Koops W,
    4. Kröger R,
    5. Van Ruth S,
    6. Witkamp AJ,
    7. Zoetmulder FAN.
    Peritoneal carcinomatosis from colorectal or appendiceal origin: correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement. J Surg Oncol. 2004; 86: 64–73.
    OpenUrlCrossRefPubMed
  26. 26.↵
    2. Coakley FV,
    3. Choi PH,
    4. Gougoutas CA,
    5. Pothuri B,
    6. Venkatraman E,
    7. Chi D, et al.
    Peritoneal metastases: detection with spiral CT in patients with ovarian cancer. Radiology. 2002; 223: 495–9.
    OpenUrlCrossRefPubMed
  27. 27.↵
    2. Low RN,
    3. Barone RM,
    4. Lucero J.
    Comparison of MRI and CT for predicting the peritoneal cancer index (PCI) preoperatively in patients being considered for cytoreductive surgical procedures. Ann Surg Oncol. 2015; 22: 1708–15.
    OpenUrl
  28. 28.↵
    2. Low RN,
    3. Barone RM.
    Combined diffusion-weighted and gadolinium-enhanced MRI can accurately predict the peritoneal cancer index preoperatively in patients being considered for cytoreductive surgical procedures. Ann Surg Oncol. 2012; 19: 1394–401.
    OpenUrlCrossRefPubMedWeb of Science
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section

Keywords